A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants
Clinical trial NCT04410094 · COMPLETED
Trial details
- NCT number
- NCT04410094
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2020-12-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.